Emteq Labs wants eyewear to be the next frontier of wearable health technology.

The Brighton, England-based company introduced today its emotion-sensing eyewear, Sense. The glasses contain nine optical sensors distributed across the rims that detect subtle changes in facial expression with more than 93 percent accuracy when paired with Emteq’s current software. “If your face moves, we can capture it,” says Steen Strand, whose appointment as Emteq’s new CEO was also announced today. With that detailed data, “you can really start to decode all kinds of things.” The continuous data could help people uncover patterns in their behavior and mood, similar to an activity or sleep tracker.

Emteq is now aiming to take its tech out of laboratory settings with real-world applications. The company is currently producing a small number of Sense glasses, and they’ll be available to commercial partners in December.

The announcement comes just weeks after Meta and Snap each unveiled augmented reality glasses that remain in development. These glasses are “far from ready,” says Strand, who led the augmented reality eyewear division while working at Snap from 2018 to 2022. “In the meantime, we can serve up lightweight eyewear that we believe can deliver some really cool health benefits.”

Fly Vision Vectors

While current augmented reality (AR) headsets have large battery packs to power the devices, glasses require a lightweight design. “Every little bit of power, every bit of weight, becomes critically important,” says Strand. The current version of Sense weighs 62 grams, slightly heavier than the Ray-Ban Meta smart glasses, which weigh in at about 50 grams.

Because of the weight constraints, Emteq couldn’t use the power-hungry cameras typically used in headsets. With cameras, motion is detected by looking at how pixels change between consecutive images. The method is effective, but captures a lot of redundant information and uses more power. The eyewear’s engineers instead opted for optical sensors that efficiently capture vectors when points on the face move due to the underlying muscles. These sensors were inspired by the efficiency of fly vision. “Flies are incredibly efficient at measuring motion,” says Emteq founder and CSO Charles Nduka. “That’s why you can’t swat the bloody things. They have a very high sample rate internally.”

Sense glasses can capture data as often as 6,000 times per second. The vector-based approach also adds a third dimension to a typical camera’s 2D view of pixels in a single plane.

These sensors look for activation of facial muscles, and the area around the eyes is an ideal spot. While it’s easy to suppress or force a smile, the upper half of our face tends to have more involuntary responses, explains Nduka, who also works as a plastic surgeon in the United Kingdom. However, the glasses can also collect information about the mouth by monitoring the cheek muscles that control jaw movements, conveniently located near the lower rim of a pair of glasses. The data collected is then transmitted from the glasses to pass through Emteq’s algorithms in order to translate the vector data into usable information.

In addition to interpreting facial expressions, Sense can be used to track food intake, an application discovered by accident when one of Emteq’s developers was wearing the glasses while eating breakfast. By monitoring jaw movement, the glasses detect when a user chews and how quickly they eat. Meanwhile, a downward-facing camera takes a photo to log the food, and uses a large language model to determine what’s in the photo, effectively making food logging a passive activity. Currently, Emteq is using an instance of OpenAI’s GPT-4 large language model to accomplish this, but the company has plans to create their own algorithm in the future. Other applications, including monitoring physical activity and posture, are also in development.

One Platform, Many Uses

Nduka believes Emteq’s glasses represent a “fundamental technology,” similar to how the accelerometer is used for a host of applications in smartphones, including managing screen orientation, tracking activity, and even revealing infrastructure damage.

Similarly, Emteq has chosen to develop the technology as a general facial data platform for a range of uses. “If we went deep on just one, it means that all the other opportunities that can be helped—especially some of those rarer use cases—they’d all be delayed,” says Nduka. For example, Nduka is passionate about developing a tool to help those with facial paralysis. But a specialized device for those patients would have high unit costs and be unaffordable for the target user. Allowing more companies to use Emteq’s intellectual property and algorithms will bring down cost.

In this buckshot approach, the general target for Sense’s potential use cases is health applications. “If you look at the history of wearables, health has been the primary driver,” says Strand. The same may be true for eyewear, and he says there’s potential for diet and emotional data to be “the next pillar of health” after sleep and physical activity.

How the data is delivered is still to be determined. In some applications, it could be used to provide real-time feedback—for instance, vibrating to remind the user to slow down eating. Or, it could be used by health professionals only to collect a week’s worth of at-home data for patients with mental health conditions, which Nduka notes largely lack objective measures. (As a medical device for treatment of diagnosed conditions, Sense would have to go through a more intensive regulatory process.) While some users are hungry for more data, others may require a “much more gentle, qualitative approach,” says Strand. Emteq plans to work with expert providers to appropriately package information for users.

Interpreting the data must be done with care, says Vivian Genaro Motti, an associate professor at George Mason University who leads the Human-Centric Design Lab. What expressions mean may vary based on cultural and demographic factors, and “we need to take into account that people sometimes respond to emotions in different ways,” Motti says. With little regulation of wearable devices, she says it’s also important to ensure privacy and protect user data. But Motti raises these concerns because there is a promising potential for the device. “If this is widespread, it’s important that we think carefully about the implications.”

Privacy is also a concern to Edward Savonov, a professor of electrical and computer engineering at the University of Alabama, who developed a similar device for dietary tracking in his lab. Having a camera mounted on Emteq’s glasses could pose issues, both for the privacy of those around a user and a user’s own personal information. Many people eat in front of their computer or cell phone, so sensitive data may be in view.

For technology like Sense to be adopted, Sazonov says questions about usability and privacy concerns must first be answered. “Eyewear-based technology has potential for a great future—if we get it right.”

Jul 10, 2023

The Salata Institute for Climate and Sustainability at Harvard University launched today a major research and outreach initiative to reduce global methane emissions. The initiative seeks meaningful and sustained progress in global methane-emissions reductions through research and effective engagement with government policymakers — and with key stakeholders in business, nongovernmental organizations, and international institutions.

Nov 8, 2023

Economic historian Emma Rothschild, the Jeremy and Jane Knowles Professor of History at Harvard, lauded the efforts of young scholars to discover local solutions to mitigate the impacts of global climate change in the latest episode of “Environmental Insights: Discussions on Policy and Practice from the Harvard Environmental Economics Program.” The podcast is produced by the Harvard Environmental Economics Program.

Nov 15, 2023

Efforts around and impacts of global methane-emissions abatement will be the focus at an official side event on December 6 co-sponsored by the Harvard Project on Climate Agreements at the 28th Conference of the Parties (COP-28) of the United Nations Framework Convention on Climate Change (UNFCCC) in Dubai. Harvard Project Director Robert Stavins will also participate in a number of other events at COP-28.

Dec 13, 2023

The Harvard Project on Climate Agreements (HPCA) assembled a panel of leading academics and government officials to discuss strategies for achieving significant methane emissions reductions at relatively low costs at an official COP 28 Side Event last Wednesday (Dec. 6). The event, titled “Reducing Global Methane Emissions: Imperatives, Opportunities, and Challenges,” was moderated by HPCA Director Robert Stavins.

Feb 14, 2024

The Harvard Project participates in a major Harvard initiative aimed at reducing emissions of methane, a powerful greenhouse gas. Participating researchers represent a range of academic disciplines and Harvard schools.

Jul 11, 2024

Efforts to measure and mitigate the impact of methane emissions was the topic of discussion last Monday (June 10, 2024) at a panel convened as part of Climate Action Week in the Northwest Building, sponsored by Harvard’s Salata Institute for Climate and Sustainability and moderated by Harvard Environmental Economics Program and Harvard Project Director Robert Stavins.

Video 1 Preview Image Caption

In order to figure out how something came from nothing, we first need to explore the different types of nothing

Election Day is upon but let's review something truly scary.

Continue reading The Time Wars: Something other than the Election at The Wild Hunt.

wait this ISN'T Liz's villain arc?!

"Oh my god, you guys! I am so excited to start physical therapy, I woke up early! What a great day! See you all at 4pm for dinner, after my nap!"

MIT chemists have devised a novel method for synthesizing complex compounds that were initially extracted from plants and have the potential as medlinkantibiotics/medlink,

A glaucoma medication, methazolamide, has been found to reduce the accumulation of tau protein in zebrafish and mice, offering potential hope for treating

Imagine your ovaries as a factory producing essential hormones. As you age, this factory's productivity declines, eventually leading to medlinkmenopause/medlink.

A newer method of calculating so-called "bad cholesterol" levels in the blood is more accurate than the older method in people who did not fast before blood was drawn.

medlinkAcupuncture/medlink can treat methadone dose and opioid cravings in patients receiving methadone maintenance therapy (MMT), suggests a new study.

A team of doctors led by Dr. Joanna Mills, a PhD candidate of the University of Sydney's Northern Clinical School, have informed that same-day inguinal

Lupin has bolstered its portfolio by introducing the generic Methergine brand into the US markets. Methergine (methylergonovine maleate) tablets are used

       The office worker is general will see much of a scene, at new of the year split a head, you nearby of person or many or little all someone drive the inner part...

Few things in life are as difficult as acknowledging mistakes, in particular those that we have made out of conviction. Choosing an unsuitable profession or...

Every traveler makes a bucket list of the places they want to explore the beauty of, and places in Rajasthan is something no one would want to let slip from their list.

Government-owned power giant NTPC announced on Friday that in "a major groundbreaking achievement," it has been "successful in the synthesis of CO2 captured from flue gas with hydrogen produced from a PEM electrolyser, which was then converted into methanol at NTPC's Vindhyachal plant."

Announcement Number: DOE-20-EIA-ES-00885
Closing Date: 23 March 2020

In the fast-paced world of social media, boosting engagement is crucial for people aiming to make an impact. With platforms constantly evolving, understanding advanced strategies can set your posts apart. This article explores effective methods to enhance interaction on your social

[s.l.] : Mohr Siebeck GmbH & Co. KG, 2023.

Cham, Switzerland : Springer, [2016]

Manchester : Manchester University Press, [2017]

Abingdon, Oxon ; New York, NY : Routledge, 2015.